LawWiki
HomeCodesSearchGlossaryAPIAbout
LawWiki

Plain English summaries of California law with zero-hallucination AI. Every summary is verified against official source text.

Product

  • Search
  • Codes
  • About

Legal

  • Privacy Policy
  • Terms of Service
  • Disclaimer

© 2026 LawWiki. All rights reserved.

HomeHealth and Safety CodeDiv. 104Pt. 5Ch. 6Art. 5§ 111595 Investigational Drug Exemption Rules

§ 111595 Investigational Drug Exemption Rules

Health and Safety Code·California
AI Summary·Official Text·Key Terms·Related Statutes·References
AI SummaryVerified

§ 111595 Investigational Drug Exemption Rules

Key Takeaways

  • •This law says some new drugs or medical tools can be tested on people without full approval, but only by experts.
  • •Before testing, the company must show animal test results to prove it’s safe to try on humans.
  • •Doctors testing the drug must promise to watch patients closely and not give the drug to others.
  • •The company must keep records and report results to check if the drug or tool is safe and works.

Example

A company creates a new medicine for headaches and wants to test it on people.

The company must first show test results from animals to prove it’s safe. Then, doctors testing it must sign a paper promising to watch patients carefully and not share the medicine. The company must also track how well the medicine works and report back.

AI-generated — May contain errors. Not legal advice. Always verify source.

Official Source
View on CA.gov

§ 111595 Investigational Drug Exemption Rules

Section 111550 does not apply to any drug or device intended solely for investigational use by experts qualified by scientific training and experience to investigate the safety and effectiveness of drugs or devices if all the following conditions are complied with: (a)  The submission to the department, before any clinical testing of a drug or device is undertaken, of reports, by the manufacturer or the sponsor of the investigation of the drug or device, of preclinical tests including tests on animals, of the drug or device adequate to justify the proposed clinical testing. (b)  The manufacturer or the sponsor of the investigation of a drug or a device proposed to be distributed to investigators for clinical testing obtaining a signed, notarized agreement from each of the investigators that patients to whom the drug or device is administered will be under his or her personal supervision, or under the supervision of investigators responsible to him or her, and that he or she will not supply the drug or device to any other investigator, or to clinics, for administration to human beings. (c)  The establishment and maintenance of the records, and the making of the reports to the department, by the manufacturer or the sponsor of the investigation of the drug or device, of data, including but not limited to, analytical reports by investigators, obtained as a result of the investigational use of the drug or device, as the department finds will enable it to evaluate the safety and effectiveness of the drug or device in the event of the filing of an application pursuant to Section 111550. (d)  The manufacturer, or the sponsor of the investigation, require experts using the drugs or devices for investigational purposes to certify to the manufacturer or sponsor that they will comply with the requirements of Article 4 (commencing with Section 111515). (e)  Any other conditions as the department shall adopt as regulations necessary for the protection of the public health. The federal regulations adopted pursuant to Section 505(i) of the federal act (21 U.S.C. Sec. 355(i)) or Section 520(g) thereof (21 U.S.C. Secs. 352 and 360) shall be the regulations for exemptions from Section 111550 in this state. However, the department may prescribe, by regulation, any condition for exemption from Section 111550 whether or not the condition is in accordance with regulations adopted under the federal act. (Added by Stats. 1995, Ch. 415, Sec. 6. Effective January 1, 1996.)

Last verified: January 23, 2026

Key Terms

investigational useSection 111550preclinical testsArticle 4federal regulations

Related Statutes

  • § 111555 Application Approval Timeline
  • § 111590 Investigational Drug Exemption
  • § 111610 Drug And Device Exemptions
  • § 101875 Public Records Enforcement Actions
  • § 102900 American Indian Vital Data

References

  • Official text at leginfo.legislature.ca.gov
  • California Legislature. Health and Safety Code. Section 111595.
View Official Source